Coordinating Care: Symptom-Directed Treatments and Your Child's Team
At a Glance
BCAP31-related DDCH has no single standard treatment plan or cure. A coordinated team tailors care for involuntary muscle stiffness, hearing loss, feeding and growth problems, and liver changes while supporting the child’s comfort, communication, mobility, and quality of life.
While there is currently no cure for BCAP31-related syndrome (DDCH), a well-coordinated team of specialists can significantly improve your child’s comfort, communication, and quality of life. Because this condition is so rare, there is no single “standard” treatment manual; instead, care is symptom-directed, meaning it is tailored to your child’s specific needs as they change over time [1][2].
Building Your Multidisciplinary Care Team
Managing DDCH requires a “village” of medical professionals. A typical care team includes:
- Pediatric Neurologist: Often the lead specialist, they manage the movement disorder (dystonia), monitor for seizures, and track brain development [1][3].
- Audiologist & ENT: These specialists monitor hearing levels and evaluate whether technologies like hearing aids or cochlear implants are appropriate [1][4].
- Geneticist: They provide the formal diagnosis and help the family understand the inheritance pattern and risks for future children [2][4].
- Gastroenterologist (GI) & Pulmonologist: Because many children have feeding difficulties, liver issues, or respiratory vulnerability, these doctors monitor organ health and ensure proper nutrition [2][5].
- Therapy Team: Physical (PT), Occupational (OT), and Speech-Language (SLP) therapists are essential for supporting mobility and communication, starting from diagnosis [5].
Possible Symptom-Directed Treatments for Dystonia
Dystonia—involuntary muscle twisting and stiffness—can be one of the most challenging symptoms to manage. The goal of treatment is not to eliminate all movements, but to maximize comfort and function.
- Medications: Doctors may trial various oral medications extrapolated from other pediatric movement disorders, such as baclofen, benzodiazepines, or anticholinergics. It is important to know that these can cause significant side effects, including sedation, worsened hypotonia, respiratory depression, and swallowing difficulty. Medication decisions require a pediatric movement-disorder clinician [6].
- Focal Treatments: For stiffness in specific muscle groups, injections of botulinum toxin (Botox) are sometimes used to temporarily relax those muscles, bearing in mind risks of focal weakness or dysphagia [7].
- Physical Therapy: Regular PT focuses on preventing contractures (permanent shortening of muscles or tendons) and helping your child find comfortable positions for sitting and sleeping [2].
Hearing Rehabilitation and Communication
Since sensorineural hearing loss is a core feature of DDCH, early intervention is vital.
- Hearing Technologies: Some children benefit from high-powered hearing aids. In selected cases of profound hearing loss, cochlear implants have been used [1]. Candidacy for implants must be carefully evaluated by your team, as syndrome-specific outcome data is limited [8][9].
- Alternative Communication (AAC): Many families find success using Total Communication, which combines any residual hearing with sign language, gestures, and Augmentative and Alternative Communication (AAC) devices (like picture boards or tablets) to help their child express their needs.
Liver and Growth Monitoring
Because liver enzyme elevations (AST and ALT) are reported in some individuals, your child will likely need regular blood work to ensure their liver remains stable [2]. If your child has a “contiguous gene deletion” (CADDS), this monitoring becomes even more critical, as the risk for severe liver issues is higher [10].
Additionally, because many children face feeding challenges or “failure to thrive,” a nutritionist or feeding specialist can help adjust their diet or recommend specialized feeding equipment if necessary [5]. Focusing on these “baseline” health factors gives your child the best foundation for their development.
Common questions in this guide
Who typically coordinates care for a child with BCAP31-related DDCH?
What options are used to manage dystonia in DDCH?
When might hearing aids or a cochlear implant be considered?
How are liver health, nutrition, and growth followed in DDCH?
How can therapy and communication tools help my child function?
How can our family track symptoms and manage caregiver stress?
Appointments are short. Make every minute count.
Specialist visits move fast. Let us help you prep so your time goes to what matters.
Care team members
Which specialists should be on my child's care team?
Movement and stiffness
Could botulinum toxin injections be an option for stiffness in certain muscles?
Hearing support
What hearing options, such as hearing aids or cochlear implants, should we discuss?
Get notified when new evidence is published on Developmental malformations-deafness-dystonia syndrome.
We monitor PubMed for new peer-reviewed studies on this topic and email a short summary when something meaningful changes.
References
References (10)
- 1
Case Report: The first Korean familial case of BCAP31-related deafness, dystonia, and cerebral hypomyelination.
Suh YA, Hwang J, Seo GH, et al.
Frontiers in pediatrics 2024; (12()):1488095 doi:10.3389/fped.2024.1488095.
PMID: 39911770 - 2
Further delineation of BCAP31-linked intellectual disability: description of 17 new families with LoF and missense variants.
Whalen S, Shaw M, Mignot C, et al.
European journal of human genetics : EJHG 2021; (29(9)):1405-1417 doi:10.1038/s41431-021-00821-0.
PMID: 33603160 - 3
BCAP31-associated encephalopathy and complex movement disorder mimicking mitochondrial encephalopathy.
Albanyan S, Al Teneiji A, Monfared N, Mercimek-Mahmutoglu S
American journal of medical genetics. Part A 2017; (173(6)):1640-1643 doi:10.1002/ajmg.a.38127.
PMID: 28332767 - 4
BCAP31-related syndrome: The first de novo report.
Rinaldi B, Van Hoof E, Corveleyn A, et al.
European journal of medical genetics 2020; (63(2)):103732 doi:10.1016/j.ejmg.2019.103732.
PMID: 31330203 - 5
Whole exome sequencing reveals a dual diagnosis of BCAP31-related syndrome and glutaric aciduria III.
Huggins E, Jackson DG, Young SP, Kishnani PS
Molecular genetics and metabolism reports 2024; (40()):101117 doi:10.1016/j.ymgmr.2024.101117.
PMID: 39101156 - 6
Long-Term Follow-Up with Video of a Patient with Deafness-Dystonia Syndrome Treated with DBS-GPi.
Dulski J, Schinwelski M, Mandat T, et al.
Stereotactic and functional neurosurgery 2016; (94(2)):123-5 doi:10.1159/000445078.
PMID: 27100856 - 7
Bilateral Globus Pallidus Internus Deep Brain Stimulation in a Case of Progressive Dystonia in Mohr-Tranebjaerg Syndrome with Bilateral Cochlear Implants.
Coenen VA, Rijntjes M, Sajonz B, et al.
Journal of neurological surgery. Part A, Central European neurosurgery 2019; (80(1)):44-48 doi:10.1055/s-0038-1669472.
PMID: 30290379 - 8
Cochlear Implantation Outcomes in Post Synaptic Auditory Neuropathies: A Systematic Review and Narrative Synthesis.
Chaudhry D, Chaudhry A, Muzaffar J, et al.
The journal of international advanced otology 2020; (16(3)):411-431 doi:10.5152/iao.2020.9035.
PMID: 33136025 - 9
Progressive deafness-dystonia due to SERAC1 mutations: A study of 67 cases.
Maas RR, Iwanicka-Pronicka K, Kalkan Ucar S, et al.
Annals of neurology 2017; (82(6)):1004-1015 doi:10.1002/ana.25110.
PMID: 29205472 - 10
Interstitial lung disease and pancreatic exocrine insufficiency in CADDS: Phenotypic expansion and literature review.
Heath O, Pandithan D, Pitt J, et al.
JIMD reports 2023; (64(5)):337-345 doi:10.1002/jmd2.12390.
PMID: 37701323
This page is for informational purposes only and does not constitute medical advice. A pediatric movement-disorder clinician and your child’s multidisciplinary team should guide medication, hearing, therapy, nutrition, and liver-monitoring decisions.